WO2006106514A3 - Electrospun dosage form and method of producing the same - Google Patents

Electrospun dosage form and method of producing the same Download PDF

Info

Publication number
WO2006106514A3
WO2006106514A3 PCT/IL2006/000430 IL2006000430W WO2006106514A3 WO 2006106514 A3 WO2006106514 A3 WO 2006106514A3 IL 2006000430 W IL2006000430 W IL 2006000430W WO 2006106514 A3 WO2006106514 A3 WO 2006106514A3
Authority
WO
WIPO (PCT)
Prior art keywords
electrospun
producing
same
dosage form
electrospun polymer
Prior art date
Application number
PCT/IL2006/000430
Other languages
French (fr)
Other versions
WO2006106514A2 (en
Inventor
Alexander Dubson
Alon Shalev
Original Assignee
Nicast Ltd
Alexander Dubson
Alon Shalev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicast Ltd, Alexander Dubson, Alon Shalev filed Critical Nicast Ltd
Publication of WO2006106514A2 publication Critical patent/WO2006106514A2/en
Publication of WO2006106514A3 publication Critical patent/WO2006106514A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Abstract

A formulation, comprising one or more electrospun polymers incorporating one or more chemicals is disclosed. In one embodiment, the electrospun polymer is pharmaceutically acceptable, and the chemical comprise one or more pharmaceutically active ingredients. The shape and size of the electrospun polymer is can be adapted for oral, vaginal or rectal administration.
PCT/IL2006/000430 2005-04-06 2006-04-05 Electrospun dosage form and method of producing the same WO2006106514A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66861405P 2005-04-06 2005-04-06
US60/668,614 2005-04-06

Publications (2)

Publication Number Publication Date
WO2006106514A2 WO2006106514A2 (en) 2006-10-12
WO2006106514A3 true WO2006106514A3 (en) 2007-05-31

Family

ID=37073852

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2006/000430 WO2006106514A2 (en) 2005-04-06 2006-04-05 Electrospun dosage form and method of producing the same

Country Status (1)

Country Link
WO (1) WO2006106514A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100166854A1 (en) * 2006-10-30 2010-07-01 Rutgers, The State University Of New Jersey Electrospun matrices for delivery of hydrophilic and lipophilic compounds
KR100937625B1 (en) * 2007-08-10 2010-01-20 주식회사 제닉 Dissolvable Web Porous Film and Preparing Method Thereof
AU2009234203B2 (en) * 2008-04-11 2014-06-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
CA2803377C (en) 2010-07-02 2018-03-20 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
JP5859526B2 (en) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー Filaments containing an activator nonwoven web and methods for making the same
WO2012003367A2 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Method for delivering an active agent
RU2543892C2 (en) 2010-07-02 2015-03-10 Дзе Проктер Энд Гэмбл Компани Production of films from nonwoven webs
CN103003476B (en) 2010-07-02 2016-02-10 宝洁公司 Web material and the method for the manufacture of web material
BR112012033600A2 (en) 2010-07-02 2016-11-29 Procter & Gamble Comapny filaments comprising ingestible nonwoven webs and methods of manufacturing them.
CZ308409B6 (en) * 2013-02-26 2020-08-05 Elmarco S.R.O. Preparation for the administration of at least one biologically and / or pharmaceutically active substance
EP2810645B1 (en) * 2013-06-06 2017-05-24 A. Sezai Sarac New Drug Delivery System
MX2016015688A (en) 2014-06-10 2017-05-30 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa.
US10828387B2 (en) 2015-11-12 2020-11-10 St. Teresa Medical, Inc. Method of sealing a durotomy
WO2018133910A1 (en) 2017-01-23 2018-07-26 Dermtreat Aps Method for preparing electrospun fibers with a high content of a bioadhesive substance
RU2019125715A (en) 2017-01-23 2021-02-24 Афикс Терапьютикс А/С METHOD FOR PRODUCING TWO-LAYER PRODUCT BASED ON ELECTRICALLY SPOTTED FIBERS
WO2018140675A1 (en) 2017-01-27 2018-08-02 The Procter & Gamble Company Compositions in the form of dissolvable solid structures comprising effervescent agglomerated particles
US10953128B2 (en) 2017-11-02 2021-03-23 St. Teresa Medical, Inc. Fibrin sealant products
KR102433420B1 (en) 2018-01-26 2022-08-18 더 프록터 앤드 갬블 캄파니 Water-Soluble Articles and Related Methods
KR20200085891A (en) 2018-01-26 2020-07-15 더 프록터 앤드 갬블 캄파니 Water soluble unit dose article containing fragrance
WO2019147532A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
KR20200086739A (en) 2018-01-26 2020-07-17 더 프록터 앤드 갬블 캄파니 Water soluble unit dose article containing enzyme
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
US11859338B2 (en) 2019-01-28 2024-01-02 The Procter & Gamble Company Recyclable, renewable, or biodegradable package
EP3712237A1 (en) 2019-03-19 2020-09-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
JP7381613B2 (en) 2019-06-28 2023-11-15 ザ プロクター アンド ギャンブル カンパニー Dissolvable solid fibrous article containing anionic surfactant
MX2023001042A (en) 2020-07-31 2023-02-16 Procter & Gamble Water-soluble fibrous pouch containing prills for hair care.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036973A (en) * 1994-06-27 2000-03-14 Alza Corporation Therapy for neurological diseases
US6790528B2 (en) * 2000-08-18 2004-09-14 Transmit Gesellschaft Fuer Technologietransfer Mbh Production of polymer fibres having nanoscale morphologies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036973A (en) * 1994-06-27 2000-03-14 Alza Corporation Therapy for neurological diseases
US6790528B2 (en) * 2000-08-18 2004-09-14 Transmit Gesellschaft Fuer Technologietransfer Mbh Production of polymer fibres having nanoscale morphologies

Also Published As

Publication number Publication date
WO2006106514A2 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
WO2006106514A3 (en) Electrospun dosage form and method of producing the same
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
WO2007095600A3 (en) Disintegrable oral films
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
EP1120109A3 (en) Rapidly disintegrating and fast dissolving solid dosage form
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
WO2003080023A3 (en) Fast dissolving dosage forms having reduced friability
EP2258345A3 (en) Solid pharmaceutical dosage form comprising an HIV protease inhibitor solid dispersion
WO2011049706A8 (en) Orally transformable tablets
EP2322146A3 (en) Microcapsule formulations comprising two pharmaceutically active ingredients
WO2007074472A3 (en) Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide
WO2006063249A3 (en) Functionalized poly (ether-anhydride) block copolymers
WO2007109057A3 (en) Solid dosage form containing a taste masked active agent
EP2444072A3 (en) Non-mucoadhesive film dosage forms
WO2005097076A3 (en) Low dose pharmaceutical products
WO2006030402A3 (en) Dual compartment osmotic delivery device
WO2007144169A3 (en) Entacapone-derivatives
ATE387937T1 (en) PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS CONTAINING LACTIC ACID POLYMER AND HYDROXYNAPHTHALINE CARBONIC ACID, AND THEIR PRODUCTION
TW200603840A (en) Bioadhesive dosage form of steroids
WO2009106824A3 (en) Pharmaceutical formulations with a taste masking coating
WO2005107753A3 (en) Naltrexone long acting formulations and methods of use
NO20055601D0 (en) Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients
WO2008087323A3 (en) Galenic form for the transmucosal delivery of paracetamol
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
PA8548301A1 (en) PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06728231

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6728231

Country of ref document: EP